Biotechnology

Editas Medicine is a leading genome editing company focused on translating the power and promise of our proprietary genome editing systems into medicines to help transform the lives of people with genetically-defined diseases. Their goal is to discover, develop, manufacture, and commercialize transf

Mirada Medical is a prominent global brand in medical imaging software. Mirada’s innovative software solutions are routinely used in

Sanity Group is a holistic European Cannabis company focusing on health, wellbeing, and scientific research.

SalubrisBio was founded in August 2016 as a subsidiary of the China-based pharmaceutical company Salubris Pharmaceuticals Co. Ltd. (www.salubris.com). SalubrisBio is an innovation-focused biotech with pioneering research and development programs. Headquartered in Gaithersburg, Maryland, SalubrisBio

DermTech brings precision to the practice of dermatology through non-invasive genomic testing. The DermTech Smart Sticker collects an RNA sample by painlessly lifting skin cells off the entire surface of a mole. This gives doctors the power to diagnose skin cancer in its earliest stages—without a sc

Needle-free vaccination and vaccine delivery solutions that safely and cost effectively amplify vaccine efficacy using Nanopatch technology developed by Vaxxas.

The J. Craig Venter Institute was formed in October 2006 through the merger of several affiliated and legacy organizations — The Institute for Genomic Research (TIGR) and The Center for the Advancement of Genomics (TCAG), The J. Craig Venter Science Foundation, The Joint Technology Center, and the I

One revolutionary idea. One promising clinical trial. One new breakthrough. Discovering and developing new drugs and better treatments that save lives and making them accessible to all communities is how Massey is moving toward a future without cancer.

Rockwell Medical Inc. is a publicly traded biopharmaceutical company founded in 1996 in Michigan.

Vanguard Clinical specializes in clinical trial management that carry out trials and research for drug development.

Eikonoklastes is advancing a new generation of tissue factor (TF) immunotherapies – therapeutics designed to target the cell surface receptor now known to be prevalent on key components of the tumor microenvironment.

EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells.

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.

Rapid Micro Biosystems accelerates the detection of microbial contamination in the manufacture of pharmaceuticals, biologics, medical devices, and personal care products. The company’s Growth Direct™ Platform—the first and only growth-based platform to fully automate traditional microbial testing—de

Sino Biological is a specialist provider of protein, antibody and gene products.

Apertura Gene Therapy is a biotechnology company opening opportunities for treating debilitating diseases with limited options for patients.

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines.

Ensoma believes every person, no matter where they are, should have access to innovative technologies that are changing the way we treat disease. Harnessing the power of their Engenious™ vectors, their therapies can be delivered in a simple, single injection.

FogPharma is dedicated to the creation of a new class of medicines that target human disease drivers currently considered “undruggable.” The company’s cell-penetrating miniproteins (CPMPs) combine the targeting power of protein therapeutics with the cell-penetrating ability of small molecules. This

Andes empowers biology to enable positive action against climate change.

T-knife is a fast-growing, pre-clinical-stage biopharmaceutical company developing tumor-specific T cell receptor (TCR) therapies.

Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease.

Cambrian’s water solutions solve resource challenges for food and beverage producers.

As a global Contract Research Organization (CRO), we offer a diverse slate of Clinical Development and Resourcing solutions reflecting both Full-service CRO and Functional Service Provider (FSP) models. In supporting Clinical Outsourcing needs for emerging biotech and pharmaceutical companies—most n

Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

We are a global leader in applied molecular biology diagnostics, with solutions and services that deliver accurate and actionable feedback in bioprocessing, biofouling, and biosecurity applications. Founded in 1995 and with operations in six countries, LuminUltra serves dozens of Fortune 500 custome

DAVA Oncology was founded in 2007 with the goal of facilitating successful cancer drug development by providing innovative solutions and services to the pharmaceutical and biotechnology industries. DAVA has three business units - DAVA Clinical Trial Acceleration Services, Oncology Meeting Innovation

Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders.

VISION To make a difference in the lives of people globally through our innovative medicines, vaccines, and animal health products. We are committed to being the premier, research-intensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the f

Cemvita is the standard for biosolutions in the energy industry. Nature-inspired technologies are humanity’s most powerful allies in the fight against climate change. The microbes we engineer at Cemvita can fully decarbonize the most intensive industrial processes and massively shrink their overall

Luna Innovations develops sensing and instrumentation products for the healthcare, telecommunications, energy and defense sectors.

Cellular Technology Limited (CTL) has been pioneering the ELISPOT technology for immune monitoring. For nearly 20 years, CTL’s mission has been “Elevating ELISPOT to an Exact Science”. Serving over 2,000 clients from academia and industry worldwide, CTL offers unparalleled expertise in immune monito

Sanguine Biosciences is a pioneer of in-home specimen collection and a leader in direct-to-patient recruitment and digital health innovation. They partner with researchers on their study designs and support cross-sectional and longitudinal analyses with complex patient inclusion/exclusion sample col

EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in Farmington and Branford, CT. Building upon research that originates from the Sidi Chen Lab at Yale University, EvolveImmune is leveraging a novel in vivo target discovery platform to develop a broad portfolio of

Imricor Medical Systems develops magnetic resonance imaging compatible electrophysiology tools for the treatment of cardiac arrhythmias.

BiomeBank is a clinical stage biotechnology company developing microbial therapies to treat unmet medical need globally, with an immediate focus on the APAC region. We currently manufacture a microbial therapy to treat Clostridoides difficile, a potentially life threatening infection, and are positi

SQ Innovation is a privately-held Swiss biopharmaceutical company located in Zug, Switzerland, and Burlington, MA,. The company was established to develop and commercialize innovative cost-effective therapies for subcutaneous delivery of pharmaceutical products where and when needed. Its first produ

Acelot is treating functional protein misfolding diseases where the appropriate therapeutic mechanism is a restoration of the normal protein homeostasis. Functional misfolded proteins are found in various diseases such as ALS, FTD, Parkinson’s, diabetes and cancer. Acelot’s platform combines generat

Golden Age Health (GAH) is a fast-growing pharma platform dedicated to accelerating patient access to life-changing therapies for rare and specialty diseases in high-unmet-need markets. Led by former C-suite executives from Biogen, Merck, and other global leaders, we bridge the gap between proven in

Life Biosciences is developing innovative therapies to transform how we treat diseases by targeting aging biology.

Rentschler Biopharma SE is a global full-service contract manufacturer with more than 35 years of experience.

The Leader In The Integration of Naqli and Aqli Knowledge USIM offers a fresh alternative in providing a more comprehensive understanding of the global challenge by making Quran and Sunnah as the foundation of its curriculum. Pioneering Islamic Science USIM

Landmark Bio is a biotechnology industry.

A pioneer in the field of epigenetics and chromatin biology, EpiCypher is a bioscience company developing transformative technologies and delivering superior products to researchers worldwide.

ABL Inc. is a biotechnology firm providing contract research, development and manufacturing.

Scholar Rock is discovering and developing a new class of biologic therapies

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important

Matrix Meats develops and manufactures nanofiber scaffolds to support the production of cultivated meat.

Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options.

Encoded leverage the power of the human genome to deliver highly effective precision therapies, leading to life-changing and lasting benefits for individuals with genetic disorders.